The "broken" process behind listing medication on the PBS contributes to hundreds of thousands of Australians with diabetes missing out on subsidised lifesaving medication, according to the peak industry body.
Australia's Pharmaceutical Benefits Advisory Committee is reviewing MS drug prices after drugmakers rejected a 50% cut. This dispute could force 10,000 MS patients to pay $33,000 annually for treatments like Ocrevus and Kesimpta, raising fears for their lives and quality of care.
New research reveals Karenia cristata, the algae behind South Australia's massive 2025 algal bloom, is the most toxic species of its kind studied. Even low concentrations caused significant marine mortality, impacting coastal wildlife for over a year.
Heavy rainfall has transformed Australia's Channel Country into a rare bird haven, attracting species like the golden-headed cisticola inland. While exciting for birdwatchers, experts note a slight concern for potential bird flu spread.
Solomon Islands PM Matthew Wale condemned China's missile test, signaling a shift from the region's 'friends to all' policy. Leaders from Fiji and PNG also voiced concerns, highlighting historical trauma from nuclear testing. This marks a significant change for the Solomon Islands, previously a close China ally.
Oral care company Hismile is facing criticism for using "misleading" social media ads. The ads feature sales professionals and staff dressed as health workers, some using AI-generated imagery, and include a clip of a woman banned from providing health services. This follows a recent fine for similar advertising practices.
NATO leaders announced arms deals worth approximately $72 billion at a summit in Türkiye, signaling increased defense spending in Europe. US President Donald Trump agreed to lift sanctions on Türkiye and expressed willingness to sell F-35 jets, but also voiced disappointment with allies' support for the US war with Iran.
